Table 3 Prevalence of total symptoms (number of pain sites (NPS) + number of non-muscular symptoms (NN-MS)) by gender
Total symptoms | Men (N = 1455) | Women (N = 1772) | Total (N = 3227) |
|---|---|---|---|
(NPS+ NN-MS) | % (95% CI) | % (95% CI) | % (95% CI) |
0 | 11.5 (9.9 to 13.2) | 5.4 (4.4 to 6.5) | 8.1 (7.2 to 9.1) |
1 | 11.7 (10.2 to 13.5) | 8.0 (6.8 to 9.4) | 9.7 (8.7 to 10.7) |
2 | 9.6 (8.1 to 11.2) | 9.4 (8.1 to 10.4) | 9.4 (8.5 to 10.5) |
3 | 11.2 (9.6 to 12.9) | 7.5 (6.4 to 8.8) | 9.1 (8.2 to 10.2) |
4 | 9.1 (7.8 to 10.7) | 8.7 (7.5 to 10.1) | 8.9 (7.9 to 9.9) |
5 | 8.4 (7.1 to 9.9) | 7.8 (6.7 to 9.2) | 8.1 (7.2 to 9.1) |
6 | 6.9 (5.7 to 8.3) | 7.2 (6.1 to 8.5) | 7.0 (6.2 to 8.0) |
7 | 6.4 (5.3 to 7.8) | 7.2 (6.1 to 8.5) | 6.8 (6.0 to 7.7) |
8 | 5.3 (4.3 to 6.6) | 6.1 (5.1 to 7.4) | 5.8 (5.0 to 6.6) |
9 | 4.4 (3.4 to 5.6) | 4.9 (3.9 to 6.0) | 4.6 (3.9 to 5.4) |
10 | 4.7 (3.7 to 5.9) | 5.6 (4.7 to 6.8) | 5.2 (4.5 to 6.0) |
11 | 3.1 (2.3 to 4.2) | 4.7 (3.8 to 5.8) | 4.0 (3.3 to 4.7) |
12 | 2.2 (1.5 to 3.0) | 4.0 (3.1 to 5.0) | 3.1 (2.6 to 3.8) |
13 | 2.1 (1.5 to 3.0) | 3.6 (2.8 to 4.6) | 2.9 (2.4 to 3.6) |
14 | 1.3 (1.8 to 2.1) | 2.1 (1.5 to 2.9) | 1.7 (1.3 to 2.3) |
15 | 1.8 (0.5 to 1.5) | 2.5 (1.8 to 3.3) | 1.7 (1.3 to 2.3) |
16 | 0.7 (0.4 t 1.3) | 1.6 (1.1 to 2.3) | 1.2 (0.9 to 1.6) |
17 | 0.6 (0.3 to 1.2) | 1.6 (1.1 to 2.4) | 1.2 (0.9 to 1,6) |
18 | 0.1 (0-0.5) | 0.9 (0.5 to 1.5) | 0.6 (0.4 to 0.9) |
19 | 0.4 (0.1 to 0.8) | 0.4 (0.2 to 0.8) | 0.4 (0.2 to 0.7) |
20 | 0.1 (0 to 0.5) | 0.2 (0.1 to 0.6) | 0.2 (0.1 to 0.4) |
21 | 0 (0 to0.2) | 0.4 (1.2 to 0.8) | 0.2 (0.1 to 0.5) |
22 | 0.1 (0 to 0.5) | 0.2 (0.1 to 0.6) | 0.2 (0.1 to 0.4) |
23 | 0 (0 to 0.2) | 0 (0 to 0.2) | 0 (0 to 0.1) |